|
|
Volumn 15, Issue 2, 2001, Pages 80-88
|
|
A focus group on cognition-enhancing medications in Alzheimer disease: Disparities between professionals and consumers
a
e
NONE
|
|
Author keywords
Cholinesterase inhibitors; Cognition enhancement; Ethics; Quality of life
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
NOOTROPIC AGENT;
AGED;
ALZHEIMER DISEASE;
CAREGIVER;
CLINICAL ARTICLE;
CLINICAL PRACTICE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
MALE;
PATIENT MONITORING;
PHYSICIAN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
AGED;
ALZHEIMER DISEASE;
ATTITUDE OF HEALTH PERSONNEL;
COGNITION DISORDERS;
FOCUS GROUPS;
HUMANS;
NOOTROPIC AGENTS;
PILOT PROJECTS;
QUALITY OF LIFE;
|
|
EID: 0035004351
PISSN: 08930341
EISSN: None
Source Type: Journal
DOI: 10.1097/00002093-200104000-00007 Document Type: Conference Paper |
|
Times cited : (29)
|
|
References (5)
|
